Overview
Protein foundation models and AI biomolecular design
Funding
Amounts as reported; USD estimates shown only when they matchListed 2 funding records.
No chartable funding estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 9, 2026 | Hundreds of millions of RMB · Strategic | Gaorong Capital, 上海生物医药创新转化基金, 国科, 指数资本, 星连资本, 达晨财智 | No source link |
Evidence BioGeometry raises hundreds of millions of RMB in strategic financingOn 2026-06-09, according to Xiniu Data, BioGeometry completed strategic financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund, co-lead investor Guoke Investment, co-lead investor Dachencaizhi, co-lead investor Xinglian Capital, participating investor Gaorong Capital, participating investor Zhishu Capital. The company is a provider of generative AI protein design platforms. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Jun 19, 2024 | Undisclosed · Pre-Series A | Gaorong Capital, Zhipu AI, 将门创投, 盛景嘉成 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 2 valuation records.
No chartable valuation estimates yet.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Jun 9, 2026 | — · Strategic | Gaorong Capital, 上海生物医药创新转化基金, 国科, 指数资本, 星连资本, 达晨财智 | No source link |
Evidence BioGeometry raises hundreds of millions of RMB in strategic financingOn 2026-06-09, according to Xiniu Data, BioGeometry completed strategic financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund, co-lead investor Guoke Investment, co-lead investor Dachencaizhi, co-lead investor Xinglian Capital, participating investor Gaorong Capital, participating investor Zhishu Capital. The company is a provider of generative AI protein design platforms. Translated source brief, not a quotation. Check the original before citing. Sources · 0
| |||
| Jun 19, 2024 | — · Pre-Series A | Gaorong Capital, Zhipu AI, 将门创投, 盛景嘉成 | No source link |
Evidence No source brief is attached to this record. Sources · 0
| |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchNo revenue records are listed yet.
No revenue rows to list.
Team, products & investors
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
蛋白质基础模型与 AI 生物分子设计